Elevated serum semicarbazide-sensitive amine oxidase activity in non- insulin-dependent diabetes mellitus: Correlation with body mass index and serum triglyceride

Metabolism: Clinical and Experimental

Volumn 48, Issue 1, 1999, Pages 113-117

  Mészáros, Zsuzsa ^a   Szombathy, Tamás ^a   Raimondi, Laura ^a   Karádi, István ^a   Romics, László ^a   Magyar, Kálmán ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); GLYCOSYLATED HEMOGLOBIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CORONARY RISK; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ENZYME ASSAY; ENZYME BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032930354     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90019-7     Document Type: Article

References (31)

1. Callingham BA, Barrand MA: Some properties of semicarbazide-sensitive amine oxidases. J Neural Transm Suppl 23:37-54, 1987
2. Precious E, Lyles GA: Properties of a semicarbazide-sensitive amine oxidase in human umbilical artery. J Pharm Pharmacol 40:627-633, 1988
3. Raimondi L, Pirisino R, Banchelli G, et al: Further studies on semicarbazide-sensitive amine oxidase activities (SSAO) of white adipose tissue. Comp Biochem Physiol B Biochem Mol Biol 102:953-960, 1992
4. Yu PH, Zuo DM: Characterization of human serum and umbilical artery semicarbazide-sensitive amine oxidase (SSAO). Species heterogeneity and stereoisomeric specificity. Biochem Pharmacol 47:1055-1059, 1994
5. Lyles GA: Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: Biochemical, pharmacological and toxicological aspects. Int J Biochem Cell Biol 28:259-274, 1996
6. Holt A, Sharman DF, Callingham BA: Effects in-vitro of procarbazine metabolites on some amine oxidase activities in the rat. J Pharm Pharmacol 44:494-499, 1992
7. Callingham BA, Holt A, Elliott J: Some aspects of the pharmacology of semicarbazide-sensitive amine oxidases. J Neural Transm Suppl 32:279-290, 1990
8. Yu PH, Zuo DM: Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells - Possible consequences for diabetes. Diabetes 42:594-603, 1993
9. Nilsson SE, Tryding N, Tuffvesson G: Serum monoamine oxidase in diabetes mellitus and some other internal diseases. Acta Med Scand 184:105-108, 1968
10. Tryding N, Nilsson SE, Tuffvesson G, et al: Physiological and pathological influences on serum monoamine oxidase level. Scand J Clin Lab Invest 23:79-84, 1969
11. Boomsma F, Derkx FH, van den Meiracker AH, et al: Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin. Clin Sci (Colch) 88:675-679, 1995
12. Hayes BE, Clarke DE: Semicarbazide-sensitive amine oxidase activity in streptozotocin diabetic rats. Res Commun Chem Pathol Pharmacol 69:71-83, 1990
13. Elliott J, Fowden AL, Callingham BA, et al: Physiological and pathological influences on sheep blood plasma amine oxidase: Effect of pregnancy and experimental alloxan-induced diabetes mellitus. Res Vet Sci 50:334-339, 1991
14. World Health Organization Study Group: Diabetes mellitus. World Health Organ Tech Rep Ser 727:1-5, 1985
15. Yu PH, Zuo DM: Inhibition of a type B monoamine oxidase inhibitor, (E)-2(4-fluorophenethyl)-3-fluoroallylamine (MDL-72974A), on semicarbazide sensitive amine oxidases isolated from vascular tissues and sera of different species. Biochem Pharmacol 43:307-312, 1992
16. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye-binding. Anal Biochem 72:248-254, 1976
17. Yu PH: Oxidative deamination of aliphatic amines by rat aorta semicarbazide-sensitive amine oxidase. J Pharm Pharmacol 42:882-884, 1990
18. Lyles GA, Holt A, Marshal CMS: Further studies on the metabolism of methylamine by semicarbazide sensitive amine oxidase activities in human plasma, umbilical artery and rat aorta. J Pharm Pharmacol 42:322-338, 1990
19. Stehouwer CDA, Lambert J, Donker AJM, et al: Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 34:55-68, 1997
20. Yu PH, Davis BA, Zuo DM: Deamination of aliphatic amines by type B monoamine oxidase and semicarbazide-sensitive amine oxidase; pharmacological implications. J Neural Transm Suppl 41:397-406, 1994
21. Yu PH, Zuo DM: Formaldehyde produced endogenously via deamination of methylamine. A potential risk factor for initiation of endothelial injury. Atherosclerosis 120:189-197, 1996
22. Yu PH, Zuo DM: Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: Implications for advanced glycation and diabetic complications. Diabetologia 40:1243-1250, 1997
23. Boomsma F, van Veldhuisen DJ, de Kam PJ, et al: Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure. Cardiovasc Res 33:387-391, 1997
24. Zhang X, McIntire WS: Cloning and sequencing of a copper-containing, topa quinone-containing monoamine oxidase from human placenta. Gene 179:279-286, 1996
25. Morris NJ, Ducret A, Aebersold R, et al: Membrane amine-oxidase cloning and identification as a major protein in the adipocyte plasma membrane. J Biol Chem 272:9388-9392, 1997
26. King GL: The role of hyperglycaemia and hyperinsulinaemia in causing vascular dysfunction in diabetes. Ann Med 28:427-432, 1996
27. Reaven GM, Lithell H, Landsberg L: Hypertension and associated metabolic abnormalities: The role of insulin resistance and the sympathoadrenal system. N Engl J Med 334:374-381, 1996
28. Packer M: Neurohormonal interactions and adaptations in congestive heart failure. Circulation 77:721-730, 1988
29. Yu PH, Lai CT, Zuo DM: Formation of formaldehyde from adrenaline in vivo; a potential risk factor for stress-related angiopathy. Neurochem Res 22:615-620, 1997
30. Cao Danh H, Strolin Benedetti M, Mousset A, et al: Age related changes in the activities of the amine metabolizing enzymes of rat eye. J Pharm Pharmacol 37:357-361, 1984
31. McEwen CM: Human plasma monoamine oxidase. J Biol Chem 240:2011-2017, 1965